IFP Advisors’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-22
| Closed | -$332 | – | 4624 |
|
|
2024
Q3 | $332 | Sell |
22
-610
| -97% | -$9.21K | ﹤0.01% | 3176 |
|
|
2024
Q2 | $8.96K | Buy |
+632
| New | +$8.96K | ﹤0.01% | 2377 |
|
|
2023
Q1 | – | Sell |
-2,240
| Closed | -$41K | – | 3860 |
|
|
2022
Q4 | $41K | Buy |
2,240
+45
| +2% | +$824 | ﹤0.01% | 2369 |
|
|
2022
Q3 | $41K | Buy |
2,195
+46
| +2% | +$859 | ﹤0.01% | 2522 |
|
|
2022
Q2 | $40K | Hold |
2,149
| – | – | ﹤0.01% | 2317 |
|
|
2022
Q1 | $40K | Buy |
+2,149
| New | +$40K | ﹤0.01% | 2317 |
|
|
2019
Q1 | $135K | Sell |
7,960
-3,275
| -29% | -$55.5K | 0.02% | 587 |
|
|
2018
Q4 | $171K | Sell |
11,235
-1,815
| -14% | -$27.6K | 0.01% | 920 |
|
|
2018
Q3 | $266K | Buy |
13,050
+441
| +3% | +$8.99K | 0.01% | 925 |
|
|
2018
Q2 | $237K | Buy |
12,609
+602
| +5% | +$11.3K | 0.01% | 979 |
|
|
2018
Q1 | $236K | Hold |
12,007
| – | – | 0.01% | 915 |
|
|
2017
Q4 | $236K | Buy |
12,007
+498
| +4% | +$9.79K | 0.01% | 914 |
|
|
2017
Q3 | $247K | Buy |
11,509
+597
| +5% | +$12.8K | 0.01% | 1016 |
|
|
2017
Q2 | $228K | Sell |
10,912
-16
| -0.1% | -$334 | 0.01% | 1048 |
|
|
2017
Q1 | $212K | Buy |
10,928
+1,225
| +13% | +$23.8K | 0.01% | 1083 |
|
|
2016
Q4 | $165K | Buy |
9,703
+372
| +4% | +$6.33K | 0.01% | 1150 |
|
|
2016
Q3 | $175K | Buy |
9,331
+3,106
| +50% | +$58.3K | 0.01% | 1056 |
|
|
2016
Q2 | $107K | Sell |
6,225
-1,735
| -22% | -$29.8K | 0.01% | 1297 |
|
|
2016
Q1 | $135K | Sell |
7,960
-4,355
| -35% | -$73.9K | 0.02% | 587 |
|
|
2015
Q4 | $291K | Buy |
+12,315
| New | +$291K | 0.02% | 679 |
|